课题基金 / 基金详情

A novel antiviral platform: untimely activation of viral fusion mechanisms will

A novel antiviral platform: untimely activation of viral fusion mechanisms will
新型抗病毒平台：病毒融合机制的不及时激活将
批准号：
8302529
负责人：
Anne Moscona
金额：
$37.17万
依托单位：
COLUMBIA UNIVERSITY HEALTH SCIENCES
依托单位国家：
美国
项目类别：
财政年份：
2011
资助国家：
美国
项目状态：
已结题
起止时间：
2011-03-01 至 2014-02-28
来源：
https://reporter.nih.gov/project-details/8302529
关键词：
AcuteAntiviral AgentsBindingBinding ProteinsBiological AssayCell membraneCell surfaceCellsCentral Nervous System DiseasesChronicCollaborationsCommunitiesDevelopmentDistantG-substrateHealthHendra VirusHenipavirusHumanInfectionLeadLifeLightMolecular ConformationNatureNeuraxisNipah VirusParamyxovirusPublic HealthResearch ProposalsScreening procedureStructural ModelsStructureTestingTimeTissue ModelValidationVascular EndotheliumViralViral Fusion ProteinsVirusbasebiodefensehigh throughput screeningneutralizing antibodynovelnovel therapeutic interventionparticlepathogenprematurereceptorreceptor bindingsmall molecule libraries

项目成果

Anne Moscona的其他基金

相似基金

相关文献

期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Broad spectrum inhibitors of paramyxovirus envelope proteins
Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2
Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2
Engineering protease-resistant antiviral peptide inhibitors for SARS-CoV-2
海外基金